- $1.68bn
- $1.43bn
- $655.35m
U.S. STOCKS ON THE MOVE- Western Alliance Bancorp, CoreWeave, Alphabet
U.S. STOCKS ON THE MOVE-Union Pacific, Corteva, Novocure
Novocure up after Japan approves lung cancer treatment
U.S. STOCKS ON THE MOVE-Eaton, Karman, Mobileye Global
U.S. STOCKS ON THE MOVE-Labcorp, Blackstone, L3Harris
Novocure Ltd reports results for the quarter ended June 30 - Earnings Summary
Novocure up after quarterly sales beat estimates
Novocure Q2 revenue up 6%, beats analyst estimates
Brief: Novocure To Present Data From Phase 3 Panova-3 Trial Of Tumor Treating Fields In Pancreatic Cancer At Esmo Gastrointestinal Cancers Congress 2025
Brief: Novocure To Report Second Quarter 2025 Financial Results
Brief: Novocure Says Ttfields Therapy Shows Significant Improvement In Overall Survival For Pancreatic Cancer
Brief: Novocure Announces Upcoming Investor Events
Novocure Ltd reports results for the quarter ended March 31 - Earnings Summary
Novocure rises after quarterly sales beat
Novocure rises as lung cancer therapy gets CE mark in Europe
Brief: Novocure’S Optune Lua® Receives CE Mark Approval
Novocure Ltd reports results for the quarter ended December 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Fastly, pot stocks, Lightspeed
U.S. STOCKS ON THE MOVE-Lululemon Athletica, cruise stocks, Super Micro